This is a Validated Antibody Database (VAD) review about human ARHGAP35, based on 2 published articles (read how Labome selects the articles), using ARHGAP35 antibody in all methods. It is aimed to help Labome visitors find the most suited ARHGAP35 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ARHGAP35 synonym: GRF-1; GRLF1; P190-A; P190A; p190ARhoGAP; p190RhoGAP

Knockout validation
Cell Signaling Technology
domestic rabbit monoclonal (D8Q6C)
  • western blot knockout validation; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology ARHGAP35 antibody (CST, 12164S) was used in western blot knockout validation on human samples at 1:1000 (fig 3a). Signal Transduct Target Ther (2020) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D8Q6C)
  • western blot knockout validation; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology ARHGAP35 antibody (CST, 12164S) was used in western blot knockout validation on human samples at 1:1000 (fig 3a). Signal Transduct Target Ther (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
Cell Signaling Technology ARHGAP35 antibody (Cell Signaling, 2513) was used in western blot on human samples (fig 2). Cancer Cell Int (2016) ncbi
Articles Reviewed
  1. Wen X, Wan J, He Q, Wang M, Li S, Jiang M, et al. p190A inactivating mutations cause aberrant RhoA activation and promote malignant transformation via the Hippo-YAP pathway in endometrial cancer. Signal Transduct Target Ther. 2020;5:81 pubmed publisher
  2. Chen R, Wang S, Zhang Y, Hou R, Jiang J, Cui H. CD147 promotes cell motility via upregulation of p190-B RhoGAP in hepatocellular carcinoma. Cancer Cell Int. 2016;16:69 pubmed publisher